Ovarian cancer is one of the most prevalent malignancies worldwide, presenting with advanced disease and peritoneal spread in a significant number of cases. Disease burden and quality of life impairment are significant in a huge proportion of women around the world.

Primary treatment with Cytoreductive Surgery plus HIPEC is emerging as the best treatment option as supported by well conducted studies which we present.

Faculty keyboard_arrow_down

Dr. María Clara Arroyave Surgical Oncologist at Clinica Somer in Rionegro, Colombia. Member of the Colombian Surgical Asociation (Asociacion Colombiana de Cirugia). Surgical Oncology

AIS Ambassador